• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The mechanism of exosome-mediated drug resistance in hepatoma cells

Research Project

Project/Area Number 16K09347
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Gastroenterology
Research InstitutionNiigata University

Principal Investigator

Yasunobu MATSUDA  新潟大学, 医歯学系, 准教授 (40334669)

Co-Investigator(Kenkyū-buntansha) 山際 訓  新潟大学, 医歯学総合研究科, 特任教授 (10419327)
永橋 昌幸  新潟大学, 医歯学総合病院, 研究准教授 (30743918)
小林 隆  新潟大学, 医歯学総合病院, 講師 (40464010)
若井 俊文  新潟大学, 医歯学系, 教授 (50372470)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Keywords肝がん / エクソソーム / 薬剤耐性 / シスプラチン / 消化器内科 / 肝臓学
Outline of Final Research Achievements

Recently, it has been regarded that cells secret exosome (nano-sized vesicles (20-100 nm)), which participate in various types of cell-cell communication. In this study, we examined the mechanism of exosome secretion in hepatoma cells, and found that exosome exert drug resistance to anticancer drugs. Our obtained results showed that anticancer drugs (cisplatin and 5-fluorouracil) stimulate the secretion of exosome in human hepatoma cells. When cells were incubated with anticancer drug-treated cells-derived exosome, they acquired strong resistance to anticancer drugs. We found that activated type of mTOR, a serine-threonine kinase which plays a pivotal role in the cell survival, was significantly increased in exosome. Collectively, exosome exerts drug resistance through mTOR signaling in hepatoma cells.

Academic Significance and Societal Importance of the Research Achievements

肝がんは、抗がん剤に耐性を有する悪性疾患である。本研究では、細胞から分泌される微小粒子の一種であるエクソソームに着目し、薬剤耐性との関連性を検討した。研究の結果、かんがんにおいては、細胞生存に重要なキナーゼ蛋白を多く含むエクソソームを分泌することによって抗がん剤に対する耐性を獲得していることが明らかになった。本研究により、エクソソームに着目したがん治療の有効性が示唆された。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (1 results)

All 2017

All Journal Article (1 results)

  • [Journal Article] 肝癌薬剤耐性におけるエクソソームの有用性および課題2017

    • Author(s)
      松田康伸、寺井崇二
    • Journal Title

      Medical Science Digest

      Volume: 43(7) Pages: 12-15

    • Related Report
      2017 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi